The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Doximity Inc. (DOCS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$3.37, or -9.95%, to $30.50. The Doximity Inc. has recorded 519,957 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Doximity Announces New Integration with MEDITECH.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The company is listed on the NYSE and operates within the Health Information Services industry segment. At the end of the last regular session, the stock closed at $33.87 and fluctuated between $34.39 as its day high and $33.37 as its day low. The current market capitalization of Doximity Inc. is $6.58B. A total of 2.37 million shares were traded on the day, compared to an average of 1.36M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, DOCS has seen 3 BUY and 3 SELL insider trades, representing the acquisition of 1,463,500 and the disposition of 1,463,500 shares. Over the last 12 months, there were 16 BUYs and 13 SELLs from insiders. Insiders purchased 3,515,267 shares during that period but sold 3,450,965.
In the most recent transaction, Cabral Timothy S sold 7,500 shares of DOCS for 35.00 per share on Apr 11. After the transaction, the Director now owns 4,714 company shares. In a previous transaction on Apr 03, Cabral Timothy S sold 10,000 shares at 32.00 per share. DOCS shares that Director owns now total 4,714.
Among the insiders who sold shares, Cabral Timothy S disposed of 7,500 shares on Feb 15 at a per-share price of $35.00. This resulted in the Director holding 4,714 shares of DOCS after the transaction. In another insider transaction, Cabral Timothy S sold 10,000 shares at $32.55 per share on Feb 14. Company shares held by the Director now total 4,714.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for DOCS in the last 3 months, the mean price target is $36.93 with high estimates of $47.00 and low estimates of $28.00. In terms of 52-week highs and lows, DOCS has a high of $47.46 and a low of $22.91.
As of this writing, DOCS has an earnings estimate of $0.17 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.19 per share and a lower estimate of $0.16. The company reported an EPS of $0.17 in the last quarter, which was 13.30% higher than expectations of $0.15.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DOCS’s latest balance sheet shows that the firm has $798.11M in Cash & Short Term Investments as of fiscal 2022. There were $1.09M in debt and $111.28M in liabilities at the time. Its Book Value Per Share was $4.82, while its Total Shareholder’s Equity was $878.59M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DOCS is Buy with a score of 3.72.